MYCIO Wealth Partners’s Kite Pharma, Inc. KITE Stock Holding History

MYCIO Wealth Partners’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-600	Closed	-$34K	–	796
2016 Q3	$34K	Hold	600	–	–	0.01%	407
2016 Q2	$30K	Hold	600	–	–	0.01%	407
2016 Q1	$28K	Hold	600	–	–	0.01%	394
2015 Q4	$37K	Hold	600	–	–	0.01%	328
2015 Q3	$33K	Hold	600	–	–	0.01%	352
2015 Q2	$37K	Hold	600	–	–	0.01%	337
2015 Q1	$35K	Buy	+600	New	+$40.2K	0.01%	328

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MYCIO Wealth Partners's KITE Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 600 shares — an estimated $34K sold.

MYCIO Wealth Partners first reported a position in KITE in Q1 2015 and held it in 7 quarters. The position peaked at $37K in Q4 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

MYCIO Wealth Partners reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 600 Kite Pharma, Inc. shares in Q4 2016, an estimated $34K.
MYCIO Wealth Partners first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 7 quarters.
MYCIO Wealth Partners's Kite Pharma, Inc. position peaked at $37K in Q4 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.